HBM N news, videos and press releases
For more news please use our advanced search feature.
HBM N - More news...
HBM N - More news...
- Key Figures 15.04.2024
- Key Figures 31.03.2024
- HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million
- Key Figures 15.03.2024
- Key Figures 29.02.2024
- Key Figures 15.02.2024
- Key Figures 31.01.2024
- HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year
- Key Figures 15.01.2024
- HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023
- Key Figures 31.12.2023
- Key Figures 15.12.2023
- Key Figures 30.11.2023
- AbbVie to acquire HBM portfolio company ImmunoGen for USD 10.1 billion in cash
- Key Figures 15.11.2023
- Key Figures 31.10.2023
- Key Figures 15.10.2023
- HBM Healthcare Investments activates share buyback programme
- HBM Healthcare Investments publishes Half-Year Report as at 30 September 2023 with key figures for the second quarter of the 2023/2024 financial year
- Key Figures 30.09.2023
- HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 237.22 as at 30 September 2023
- Key Figures 15.09.2023
- Key Figures 31.08.2023
- Key Figures 15.08.2023
- Key Figures 31.07.2023
- HBM Healthcare Investments publishes interim report for the quarter ended 30 June 2023 with key figures for the first three months of the 2023/2024 financial year
- Key Figures 15.07.2023
- Key Figures 30.06.2023
- Cathay Biotech raises capital and enters into major strategic collaboration with China Merchants Group
- Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
